COGT
Price
$6.88
Change
-$0.13 (-1.85%)
Updated
Mar 10, 04:59 PM (EDT)
Capitalization
782.15M
63 days until earnings call
UBX
Price
$1.60
Change
-$0.08 (-4.76%)
Updated
Mar 10, 03:21 PM (EDT)
Capitalization
28.31M
Ad is loading...

COGT vs UBX

Header iconCOGT vs UBX Comparison
Open Charts COGT vs UBXBanner chart's image
Cogent Biosciences
Price$6.88
Change-$0.13 (-1.85%)
Volume$31.91K
Capitalization782.15M
Unity Biotechnology
Price$1.60
Change-$0.08 (-4.76%)
Volume$300
Capitalization28.31M
COGT vs UBX Comparison Chart
Loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COGT vs. UBX commentary
Mar 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Buy and UBX is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 11, 2025
Stock price -- (COGT: $7.17 vs. UBX: $1.69)
Brand notoriety: COGT and UBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 68% vs. UBX: 47%
Market capitalization -- COGT: $782.15M vs. UBX: $26.99M
COGT [@Biotechnology] is valued at $782.15M. UBX’s [@Biotechnology] market capitalization is $26.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 0 FA rating(s) are green whileUBX’s FA Score has 0 green FA rating(s).

  • COGT’s FA Score: 0 green, 5 red.
  • UBX’s FA Score: 0 green, 5 red.
According to our system of comparison, UBX is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 4 TA indicator(s) are bullish while UBX’s TA Score has 4 bullish TA indicator(s).

  • COGT’s TA Score: 4 bullish, 6 bearish.
  • UBX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, UBX is a better buy in the short-term than COGT.

Price Growth

COGT (@Biotechnology) experienced а +2.58% price change this week, while UBX (@Biotechnology) price change was +2.42% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.83%. For the same industry, the average monthly price growth was -7.68%, and the average quarterly price growth was -7.34%.

Reported Earning Dates

COGT is expected to report earnings on May 13, 2025.

UBX is expected to report earnings on May 09, 2023.

Industries' Descriptions

@Biotechnology (+0.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($782M) has a higher market cap than UBX($28.3M). UBX YTD gains are higher at: 73.085 vs. COGT (-8.077). UBX has higher annual earnings (EBITDA): -20.99M vs. COGT (-271.59M). COGT has more cash in the bank: 287M vs. UBX (29M). COGT has less debt than UBX: COGT (17.5M) vs UBX (20.7M). COGT (0) and UBX (0) have equivalent revenues.
COGTUBXCOGT / UBX
Capitalization782M28.3M2,763%
EBITDA-271.59M-20.99M1,294%
Gain YTD-8.07773.085-11%
P/E RatioN/AN/A-
Revenue00-
Total Cash287M29M990%
Total Debt17.5M20.7M85%
FUNDAMENTALS RATINGS
COGT vs UBX: Fundamental Ratings
COGT
UBX
OUTLOOK RATING
1..100
5871
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
67100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8760
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

UBX's Valuation (55) in the Biotechnology industry is in the same range as COGT (82) in the Miscellaneous industry. This means that UBX’s stock grew similarly to COGT’s over the last 12 months.

COGT's Profit vs Risk Rating (67) in the Miscellaneous industry is somewhat better than the same rating for UBX (100) in the Biotechnology industry. This means that COGT’s stock grew somewhat faster than UBX’s over the last 12 months.

COGT's SMR Rating (100) in the Miscellaneous industry is in the same range as UBX (100) in the Biotechnology industry. This means that COGT’s stock grew similarly to UBX’s over the last 12 months.

UBX's Price Growth Rating (60) in the Biotechnology industry is in the same range as COGT (87) in the Miscellaneous industry. This means that UBX’s stock grew similarly to COGT’s over the last 12 months.

UBX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as COGT (100) in the Miscellaneous industry. This means that UBX’s stock grew similarly to COGT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COGTUBX
RSI
ODDS (%)
Bullish Trend 7 days ago
85%
N/A
Stochastic
ODDS (%)
Bullish Trend 7 days ago
85%
Bullish Trend 7 days ago
77%
Momentum
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 7 days ago
90%
MACD
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
85%
Bullish Trend 7 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 7 days ago
87%
Advances
ODDS (%)
Bullish Trend 11 days ago
84%
Bullish Trend 25 days ago
76%
Declines
ODDS (%)
Bearish Trend 13 days ago
83%
Bearish Trend 14 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
88%
Bullish Trend 7 days ago
74%
Aroon
ODDS (%)
Bearish Trend 7 days ago
86%
Bearish Trend 7 days ago
86%
View a ticker or compare two or three
Ad is loading...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X87222.1950001156.515600
+1.34%
Bitcoin cryptocurrency
GME24.30-0.10
-0.41%
GameStop Corp
AAPL235.93-2.10
-0.88%
Apple
SPY576.86-6.91
-1.18%
SPDR® S&P 500® ETF Trust
TSLA272.04-12.61
-4.43%
Tesla

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with HOFBF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+2.43%
HOFBF - COGT
63%
Loosely correlated
N/A
TNFA - COGT
55%
Loosely correlated
-2.57%
ENGN - COGT
48%
Loosely correlated
-0.86%
ARWR - COGT
41%
Loosely correlated
-3.39%
FATE - COGT
41%
Loosely correlated
-7.77%
More

UBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, UBX has been loosely correlated with SPRC. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if UBX jumps, then SPRC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UBX
1D Price
Change %
UBX100%
+9.03%
SPRC - UBX
36%
Loosely correlated
-2.05%
JSPR - UBX
35%
Loosely correlated
-0.90%
HOFBF - UBX
34%
Loosely correlated
N/A
ASMB - UBX
33%
Poorly correlated
-2.29%
CVAC - UBX
33%
Poorly correlated
-2.60%
More